Hot Medical Stocks To Own For 2019

tags:ARR,BDSI,REXX,CLR,HZN,FSB,

Investors have jumped onto the marijuana bandwagon in droves. Even the tiniest of cannabis companies are attracting attention, and some of their share-price increases have been nothing short of spectacular. For those who prefer to get diversified exposure to the marijuana sector, the ETFMG Alternative Harvest ETF (NYSEMKT:MJ) has held itself out as a first-moving marijuana-focused exchange-traded fund for U.S. investors. Already, the ETF has attracted more than $700 million in assets, and the recent gains for cannabis stocks make it likely that the fund will bring in even more money, especially given its 50% rise in the past six weeks.

Alternative Harvest holds nearly 40 stocks, including not only marijuana producers but also pharmaceutical and biotech companies looking at the potential uses of cannabis in the medical profession and consumer-oriented companies that have expertise in selling smokeable products. Yet four of those marijuana stocks really stand out for their impressive performance so far in 2018. All four have doubled this year, and they all seem to have potential for further growth in the future.

Hot Medical Stocks To Own For 2019: ARMOUR Residential REIT, Inc.(ARR)

Advisors' Opinion:

• [By Max Byerly]

  ARMOUR Residential REIT, Inc. (NYSE:ARR) declared a monthly dividend on Wednesday, May 30th, Wall Street Journal reports. Stockholders of record on Friday, June 15th will be paid a dividend of 0.19 per share by the real estate investment trust on Thursday, June 28th. This represents a $2.28 annualized dividend and a dividend yield of 9.72%. The ex-dividend date is Thursday, June 14th.

• [By Max Byerly]

  Teacher Retirement System of Texas lowered its stake in ARMOUR Residential REIT, Inc. (NYSE:ARR) by 35.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,270 shares of the real estate investment trust’s stock after selling 4,991 shares during the period. Teacher Retirement System of Texas’ holdings in ARMOUR Residential REIT were worth $216,000 at the end of the most recent quarter.

• [By Joseph Griffin]

  ARMOUR Residential REIT (NYSE:ARR) was the target of some unusual options trading activity on Thursday. Stock traders acquired 657 call options on the stock. This represents an increase of approximately 1,163% compared to the typical volume of 52 call options.

• [By Shane Hupp]

  IndexIQ Advisors LLC trimmed its stake in ARMOUR Residential REIT, Inc. (NYSE:ARR) by 6.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 37,484 shares of the real estate investment trust’s stock after selling 2,444 shares during the period. IndexIQ Advisors LLC owned approximately 0.09% of ARMOUR Residential REIT worth $855,000 as of its most recent SEC filing.

• [By Shane Hupp]

  Wells Fargo & Company MN decreased its position in shares of ARMOUR Residential REIT, Inc. (NYSE:ARR) by 19.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 201,989 shares of the real estate investment trust’s stock after selling 50,292 shares during the period. Wells Fargo & Company MN owned about 0.48% of ARMOUR Residential REIT worth $4,703,000 as of its most recent filing with the Securities and Exchange Commission.

Hot Medical Stocks To Own For 2019: BioDelivery Sciences International Inc.(BDSI)

Advisors' Opinion:

• [By Lisa Levin]

  BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares were also up, gaining 19 percent to $2.3272 after the company announced board restructuring plan and $50m equity financing deal led by Broadfin to "significantly strengthen" financial position.

• [By Lisa Levin] Gainers Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares climbed 154.95 percent to close at $5.15 on Thursday. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity. Tyme Technologies, Inc. (NASDAQ: TYME) jumped 33.45 percent to close at $3.87. Universal Corporation (NYSE: UVV) gained 29.72 percent to close at $62.85 after reporting fiscal Q4 results. Evolus, Inc. (NASDAQ: EOLS) shares rose 22.93 percent to close at $23.80. nLIGHT, Inc. (NASDAQ: LASR) jumped 21.52 percent to close at $36.37 following Q1 results. Hudson Technologies Inc. (NASDAQ: HDSN) gained 20.28 percent to close at $2.61. The Cato Corporation (NYSE: CATO) shares rose 19.57 percent to close at $21.45 after the company posted better-than-expected first-quarter results. AXT, Inc. (NASDAQ: AXTI) gained 18.8 percent to close at $7.90. Catasys, Inc. (NASDAQ: CATS) rose 16.33 percent to close at $6.41. HUYA Inc. (NYSE: HUYA) rose 15.68 percent to close at $23.09 on Thursday. Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) climbed 15.11 percent to close at $6.02 on Thursday after gaining 6.30 percent on Wednesday. Baird initiated coverage on Marinus Pharmaceuticals with an Outperform rating. Destination Maternity Corporation (NASDAQ: DEST) shares rose 14.48 percent to close at $3.32 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan. China Rapid Finance Limited (NYSE: XRF) gained 11.53 percent to close at $3.29 after announcing preliminary Q1 results. Bilibili Inc.. (NASDAQ: BILI) shares rose 11.33 pe
• [By Logan Wallace]

  BioDelivery Sciences International (NASDAQ:BDSI) had its target price reduced by research analysts at HC Wainwright from $4.00 to $3.50 in a research report issued to clients and investors on Wednesday. The brokerage currently has a “buy” rating on the specialty pharmaceutical company’s stock. HC Wainwright’s price objective points to a potential upside of 40.00% from the company’s current price.

Hot Medical Stocks To Own For 2019: Rex Energy Corporation(REXX)

Advisors' Opinion:

• [By Stephan Byrd]

  News stories about Rex Energy (NASDAQ:REXX) have trended somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Rex Energy earned a news impact score of 0.07 on Accern’s scale. Accern also gave news articles about the oil and gas exploration company an impact score of 45.4610840717308 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Hot Medical Stocks To Own For 2019: Continental Resources, Inc.(CLR)

Advisors' Opinion:

• [By Logan Wallace]

  Clearwater Seafoods (TSE:CLR) Director Richard Lawrence Gillis Hood sold 6,200 shares of the firm’s stock in a transaction that occurred on Monday, May 14th. The shares were sold at an average price of C$4.90, for a total value of C$30,380.00.

• [By Shane Hupp]

  KLR Group reaffirmed their buy rating on shares of Continental Resources (NYSE:CLR) in a report published on Monday morning. The brokerage currently has a $78.00 target price on the oil and natural gas company’s stock.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Continental Resources (CLR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Continental Resources (NYSE:CLR) and Chesapeake Granite Wash Trust (NYSE:CHKR) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, analyst recommendations, profitability, institutional ownership and earnings.

• [By Joseph Griffin]

  These are some of the media stories that may have effected Accern’s analysis:

  Get Continental Resources alerts: Iran's Oil Production and Exports Could Help Crude Oil Bulls (finance.yahoo.com) The Cash Flow King (investingdaily.com) Continental Resources Can Soar Without Bottlenecks (seekingalpha.com) Are Options Traders Betting on a Big Move in Continental Resources (CLR) Stock? (zacks.com) Why Aren’t Permian Oil Producers Profitable? (oilprice.com)

  Shares of NYSE CLR traded down $0.40 during mid-day trading on Tuesday, hitting $64.21. The company’s stock had a trading volume of 2,923,330 shares, compared to its average volume of 2,421,609. The firm has a market capitalization of $25.63 billion, a PE ratio of 125.90 and a beta of 1.27. The company has a current ratio of 0.93, a quick ratio of 0.85 and a debt-to-equity ratio of 1.15. Continental Resources has a one year low of $29.08 and a one year high of $69.91.

• [By Matthew DiLallo]

  Another important leader of America's oil resurgence has been Continental Resources (NYSE:CLR), which was an early mover in developing the Bakken. Since 2010, the company has grown its production at a 27% CAGR, boosting it from less than 50,000 BOE/D up to a projected 315,000 to 325,000 BOE/D by the end of this year. Continental Resources expects to grow its output another 15% to 20% next year as it continues drilling not only in the Bakken but the STACK/SCOOP plays of Oklahoma, which also hold a bounty of oil and gas resources. Those growth engines position Continental Resources to expand its output rapidly in the coming years while generating a gusher of excess cash flow in the process.

Hot Medical Stocks To Own For 2019: Horizon Global Corporation(HZN)

Advisors' Opinion:

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Horizon Global (HZN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Brian Feroldi]

  Horizon Global (NYSE:HZN) reported its second-quarter results on Aug. 7th. Investors had already been provided with a sneak peek at the towing and trailering company's results in mid-July after management announced that it was expanding its ability to borrow by $50 million. The company's second-quarter results were largely in line with those updated projections, and management reaffirmed that its turnaround remains on track. However, the year-over-year numbers did not look pretty.

• [By Brian Feroldi]

  Horizon Global (NYSE:HZN) reported its first-quarter results on May 3. The provider of branded towing and trailering equipment had already warned investors that it was going through tough times but promised that it would take action to fix its problems. Let's dig into the company's results to see if those actions are starting to pay off.

• [By Stephan Byrd]

  Horizon Global (NYSE:HZN) has earned an average rating of “Hold” from the ten research firms that are presently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $15.08.

Hot Medical Stocks To Own For 2019: Franklin Financial Network, Inc.(FSB)

Advisors' Opinion:

• [By Max Byerly]

  Franklin Financial Network (NYSE:FSB) was downgraded by research analysts at Compass Point from a “neutral” rating to a “sell” rating in a research note issued on Tuesday, The Fly reports.

• [By Lee Jackson]

  Franklin Financial Network Inc. (NYSE: FSB) was downgraded to sell from neutral at Compass Point. The stock has traded in a 52-week range of $30.30 to $42.65. The consensus price target for the company across Wall Street is $37.80. The stock closed Monday at $39.40, a rise of more than 5%.

• [By Max Byerly]

  Franklin Financial Network Inc (NYSE:FSB) – Stock analysts at Piper Jaffray Companies raised their Q3 2018 EPS estimates for shares of Franklin Financial Network in a note issued to investors on Monday, July 30th. Piper Jaffray Companies analyst W. Curtiss now expects that the financial services provider will post earnings of $0.68 per share for the quarter, up from their previous estimate of $0.66. Piper Jaffray Companies currently has a “Hold” rating and a $39.00 price target on the stock.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Franklin Financial Network (FSB)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Franklin Financial Network (FSB)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  Franklin Financial Network Inc (NYSE:FSB) was the target of a significant growth in short interest in June. As of June 15th, there was short interest totalling 836,831 shares, a growth of 66.9% from the May 31st total of 501,425 shares. Approximately 6.4% of the shares of the company are sold short. Based on an average daily volume of 392,524 shares, the short-interest ratio is presently 2.1 days.